The nm23-H1 gene product has been considered as an anti-metastatic protein
and the level of its expression has been reported to correlate inversely wi
th metastatic potential in some cancers. However, the expression of nm23-HI
gene product in the metastatic sites have not been studied in detail. We e
xamined the expression of nm23-HI gene product in surgically resected 46 pa
irs of primary lung cancers and metastatic lymph nodes by immunohistochemis
try. The positive staining of nm23-H1 gene product in primary cancers and m
etastatic lymph nodes were observed in 56.5 and 67.4%, respectively. The he
terogeneity of nm23-H1 gene product expression between primary cancers and
metastatic lymph nodes was observed in 41.3%. No correlations were found be
tween the nm23-H1 gene product expression in lung cancers and the patients
survival. No significant association was also observed between nm23-H1 gene
product expression in lymph nodes and the patients survival. There was, fu
rthermore, no correlation between the heterogeneity of nm23-H1 gene product
expression and the patients survival. In conclusion, the level of nm23-H1
gene product expression does not significantly reveal prognostic value in n
ode-positive lung cancers. Expression of nm23-H1 gene product in metastatic
lymph nodes was also unrelated to patients survival. (C) 1999 Elsevier Sci
ence Ireland Ltd. All rights reserved.